Oncology Clinical Trials List India - Oncology Clinical Research & Study Center

Swap Transplant

If you are looking for any ongoing clinical trials, try our "Clinical Research Search "

List of "Oncology" clinical trials

CTRI/2009/091/000557 A 3rd/4th Line Placebo-Controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer NSCLC.	CTRI/2009/091/000637 A bioequivalence study of Capecitabine tablets in patients of Locally Advanced or Metastatic Breast Cancer or Metastatic Colorectal Cancer	CTRI/2008/091/000081 A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer	CTRI/2010/091/000344 A clinical study of a monoclonal antibody Plus Whole-Brain Radiation Therapy (WBRT) Compared with WBRT Alone in Patients with Brain Metastases from Non Small Cell Lung Cancer.
CTRI/2008/091/000095 A clinical study on the clearance of human papilloma virus (HPV) infection in uterine cervix by "Basant" (a polyherbal cream) and curcumin soft gelatin capsule in females infected with HPV	CTRI/2008/091/000113 A clinical study on the prevention of oral Premalignant lesions by Curcumin	CTRI/2009/091/000057 A Clinical study to evaluate the effect of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin in Comparison With Paclitaxel and Carboplatin in Anaplastic Thyroid Carcinoma patients.	CTRI/2010/091/002918 A clinical study to evaluate the safety and efficacy of Endoxifen in metastatic breast cancer patients
CTRI/2009/091/001006 A clinical study to evaluate the safety and tolerability by using VRP-1620 in patients with solid tumors.	CTRI/2010/091/000610 A Clinical trial of Infusion of Nanosomal Docetaxel Lipid Suspension (Intas Pharmaceuticals Ltd.) And Taxotere® in Breast Cancer Patients.	CTRI/2009/091/000593 A Clinical trial of Investigational Agent in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast Cancer	CTRI/2010/091/000433 A clinical trial study of Sunitinib in biliary tract carcinoma after failure of first line treatment.
CTRI/2010/091/000026 A Clinical Trial Study to Compare Tivozanib to Sorafenib in Subjects With advanced Renal Cell Carcinoma.	CTRI/2010/091/001078 A Clinical Trial Study to evaluate the efficacy and safety of Palonosetron for the prevention of acute-onset and delayed-onset chemotherapy induced nausea and vomitting following the administration of either moderately or highly emetogenic chemotherapy regimens.	CTRI/2009/091/000840 A clinical trial to assess the efficacy of using a rectal bladder spacer balloon for treatment of cancer cervix	CTRI/2007/091/000017 A clinical trial to compare and study the effect of a new experimental drug AMG 706 or Bevacizumab in combination with Paclitaxel and Carboplatin in patients with Advanced Non-Squamous Non-Small Cell Lung Cancer.
CTRI/2010/091/000382 A clinical trial to compare SID530 to Docetaxel by studying how body handles each drug and how safe each drug is in patients with non-small cell lung cancer or breast cancer.	CTRI/2009/091/000607 A clinical trial to compare the effects of two chemotherapy regimens (vinflunine plus capecitabine versus capecitabine alone) in patients with advanced breast cancer.	CTRI/2008/091/000008 A clinical trial to determine the safety and efficacy of an anti-cancer drug AP23573 when given as maintenace therapy in patients with having soft-tissue or Bone cancer after they have received planned therapy	CTRI/2010/091/001344 A Clinical Trial to evaluate the Efficacy and Safety of Intravenous Infusion of Nanosomal Paclitaxel Lipid Suspension and Taxol in Metastatic Breast cancer patients.
CTRI/2009/091/000295 A clinical trial to evaluate the safety and efficacy of talaporfin sodium (activated locally using light of a specific wavelength) on liver metastases in patients with colorectal cancer	CTRI/2009/091/001066 A clinical trial to observe the effect of Pemetrexed in Combination with Cisplatin in Patients with Advanced stage IIIB/IV Non-Small Cell Lung Cancer patients in india.	CTRI/2010/091/002826 A clinical trial to study a technique of pain relief with different drugs for patients undergoing breast cancer surgery.	CTRI/2009/091/000214 A clinical trial to study safety and effects of P276-00 in combination with Gemcitabine in treatment of advanced pancreatic cancer.
CTRI/2009/091/000115 A clinical trial to study safety and effects of P276-00 in combination with radiation in patients with recurrent and /or locally advanced head and neck cancer	CTRI/2011/091/000032 A clinical trial to study the bioequivlence study of Capeciatabine in Locally Advanced Breast Cancer or Metastatic Breast Cancer or Colorectal Cancer patients under fed condition.	CTRI/2010/091/001181 A clinical trial to study the effect and safety of CT-P6 as compared to Herceptin in patients with metastatic breast cancer.	CTRI/2009/091/000834 A clinical trial to study the effect and safety of INCB007839 combined with Trastuzumab in patients with previously untreated HER2 positive metastatic breast cancer.
CTRI/2007/091/000044 A clinical trial to study the effect of a new drug SNX-1012 on mouth ulcers in Patients Receiving Cancer Treatment when compared to a placebo	CTRI/2009/091/000032 A clinical trial to study the effect of Cetuximab + Folfiri or Cetuximab + Folfox in patients with KRAS wild type metastatic Colorectal Cancer.	CTRI/2011/091/000025 A clinical trial to study the effect of chemotherapy (FOLFIRI) with or without Sunitinib Malate in patients with metastatic cancer of colon/rectum.	PROVCTRI/2008/091/000025 A clinical trial to study the effect of chemotherapy (FOLFIRI) with or without Sunitinib Malate in patients with metastatic cancer of colon/rectum.
CTRI/2009/091/000817 A clinical trial to study the effect of HKI-272 in subjects with Advanced breast cancer	CTRI/2009/091/000900 A clinical trial to study the effect of NRC-AN-019 in patients with various cancers.	CTRI/2010/091/000037 A clinical trial to study the effect of weekly paclitaxel in advanced epithelial ovarian cancer.	CTRI/2009/091/000336 A clinical trial to study the effective dose range of the study drug, Sativex, in patients with advanced cancer who experience inadequate pain relief during optimized chronic opioid therapy.
CTRI/2010/091/001098 A clinical trial to study the effects of a new drug and compare the effect of BIBW 2992 along with paclitaxel and investgators choice chemotherapy in patients with Non-Small Cell Lung Cancer failing previous erlotinib or gefitinib treatment	CTRI/2008/091/000052 A clinical trial to study the effects of Ayurvedic formulation containing Ashwagandha and Guduchi in improving the quality of life in patients of breast cancer receiving chemotherapy as treatment	CTRI/2009/091/000423 A clinical trial to study the effects of bevacizumab plus capecitabine vs. bevacizumab alone as maintenance therapy in patients with HER2-negative metastatic breast cancer that has not progressed during initial docetaxel plus bevacizumab therapy	CTRI/2010/091/000491 A clinical trial to study the effects of carboplatin / Paclitaxel and a new drug, CS- 7017, in patients with Non-Small Cell Lung Cancer.
CTRI/2010/091/000221 A clinical trial to study the effects of group intervention and self help materials among tobacco users in rural Tamilnadu.	CTRI/2010/091/001245 A clinical trial to study the effects of IMC-1121B and best supportive care (BSC) versus Placebo and BSC in patients with metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first line care.	CTRI/2010/091/000486 A clinical trial to study the effects of Lucanix (Test Drug) in patients suffering from advanced non small cell Lung Cancer who have previously responded to or have a stable disease following treatment with platinum based combination chemotherapy.	CTRI/2009/091/000219 A clinical trial to study the effects of Nanoparticle based Paclitaxel drug, which does not contain the solvent cremophor, in advanced breast cancer
CTRI/2009/091/000739 A clinical trial to study the effects of Nimotuzumab in cervical cancer patients.	CTRI/2009/091/001086 A clinical trial to study the effects of Oprelvekin in patients with in prevention and treatment of chemotherapy induced thrombocytopenia in adult cancer patients.	CTRI/2010/091/001195 A Clinical Trial to study the effects of Rituximab in patients with Non Hodgkin`s Lymphoma.	CTRI/2010/091/000526 A clinical trial to study the effects of Silodosin in patients with Benign Prostatic Hyperplasia.
CTRI/2009/091/000302 A clinical trial to study the effects of study drug in patients with Non-Metastatic Hormaone resistant Prostrate Cancer Patients	CTRI/2009/091/000694 A clinical trial to study the effects of two drugs Peg G-CSF and Grafeel® in the prevention of reduction in neutrophil counts in cancer patients caused by drugs used to treat cancer.	CTRI/2009/091/000964 A clinical trial to study the effects of two drugs, naftopidil and tamsulosin in patients with benign prostatic hyperplasia.	CTRI/2010/091/006141 A clinical trial to study the effects of two drugs, ozarelix and goserelin in men with prostate cancer
CTRI/2009/091/000071 A clinical trial to study the effects of two forms of reconstruction, uncut roux-en-y gastrojejunostomy and standard roux-en-y gastrojejunostomy following partial gastrectomy or palliative bypass in patients with cancer of stomach	CTRI/2007/091/000013 A clinical trial to study the effects, (side effects and efficacy) of two combinations of chemotherapy drugs, (Paclitaxel, ifosfamide and Cisplatin) with (Paclitaxel, cisplatin and 5-FU) in patients with Locally Advanced Head and Neck Cancer	CTRI/2010/091/002829 A clinical trial to study the efficacy and safety of a regional block- bilateral superficial cervical plexus block using bupivacaine as the local anesthetic and clonidine as adjuvant with normal saline as control in patients undergoing elective thyroid surgery under general anesthesia	CTRI/2010/091/001348 A CLINICAL TRIAL TO STUDY THE EFFICACY AND SAFETY OF PT 107 (VACCINE) IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
CTRI/2008/091/000117 A clinical trial to study the efficacy of probiotic Lactobacillus brevis lozenges in preventing radiation and chemotherapy induced oral mucositis in head and neck cancer patients.	CTRI/2009/091/001042 A clinical trial to study the efficacy of probiotic VSL#3 on chemotherapy-induced diarrhoea in cancer patients recieving Fluropyrimidines/Irinotecan.	CTRI/2010/091/000232 A CLINICAL TRIAL TO STUDY THE EVALUATION OF CHANGE IN QUALITY OF LIFE IN PATIENTS WITH SOLID TUMORS UNDERGOING CHEMOTHERAPY-BY GUIDELINES BASED SELF MANAGEMENT OF SIDE EFFECTS.	CTRI/2009/091/000316 A clinical trial to study the pharmacokinetic comparision of two formulations of Docetaxel injections in Advanced Solid Tumor Patients
CTRI/2009/091/000441 A clinical trial to study the pharmacokinetic comparison of two formulations for Intravenous Infusion of Paclitaxel in Indain Patients with Metastatic Breast Cancer.	CTRI/2010/091/000015 A clinical trial to study the prediction of result of chemotherapy in Acute myeloid leukemia by evaluating in vitro DNA damage.	CTRI/2009/091/000016 A clinical trial to study the safety and efficacy of ALD518 in patients with non-small cell lung cancer-related fatigue and cachexia.	CTRI/2010/091/001247 A clinical trial to study the safety and efficacy of AYUSH QOL 2C in patients of non metastatic breast cancer receiving chemotherapy
CTRI/2009/091/000021 A clinical trial to study the safety and efficacy of herbal medicine URAL- BPH in the treatment of Benign Prostate Hyperplasia.	CTRI/2009/091/000795 A clinical trial to study the safety and efficacy of Non-pegylated Liposomal Doxorubicin (Nudoxa) as compared to doxorubicin in patients with metastatic breast cancer.	CTRI/2009/091/000204 A clinical trial to study the safety and efficacy of NRC-AN-019 in patients with Chronic Myeloid Leukemia who are not responding or intolerant to Imatinib mesylate	CTRI/2010/091/000283 A clinical trial to study the safety, efficacy and pharmacokinetics of Goserelin acetate in subjects with advanced prostate cancer.
CTRI/2010/091/000194 A CLINICAL TRIAL TWO COMPARE TO TREATMENT SCHEDULES OF CONCURRENT CHEMORADIATION IN LOCALLY ADVANCED CANCER OF CERVIX.	CTRI/2009/091/000806 A comparative evaluation of efficacy, safety & tolerability of Silodosin Capsules 4 mg, with Urief Capsules, in-patients suffering from dysurea associated with benign prostatic hyperplasia.	CTRI/2009/091/000568 A Dose tolerability & Efficacy Study of RX-0201 plus Gemcitabine in Metastatic Pancreatic Cancer	CTRI/2010/091/001135 A Multi Centre, Pilot Phase II Trial Assessing The Efficacy And Safety Of Bevacizumab + Gemcitabine + Carboplatin As First Line Treatment For Patients Diagnosed With Triple Negative Metastatic Breast Cancer.
CTRI/2010/091/002933 A multi-centre, open label, Phase IV, interventional study to see the effect of Erlotinib (Tarceva®) aftre 4 cycles of platinum-based chemotherapy in patients with locally developed or metastatic non small cell lung cancer (NSCLC) who disease has not progressed or did not had unacceptable toxicity during chemotherapy.	CTRI/2011/091/000249 A multi-centric post marketing study to evaluate the efficacy and safety of Imatinib in patients with Chronic Myelogenous Leukemia Chronic Phase (CML- CP).	CTRI/2009/091/000244 A Multicenter, Multinational, Randomized, Open-Label, Parallel-Group Trial to Evaluate the Safety of Fentanyl TAIFUN® Treatment after Titrated Dose Administration and the Current Breakthrough Pain Treatment for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy	CTRI/2009/091/000382 A Multicenter, Open-Label, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of NKTR-102 (PEG-Irinotecan) Versus Irinotecan in Patients with Second-Line, Irinotecan-Naïve, KRAS-Mutant, Metastatic Colorectal Cancer (mCRC).
CTRI/2009/091/000243 A multicentre, multinational, randomizedm Double-Blind, Placebo Controlled, crossover trial to evaluate efficacy and safety of Fentanyl TAIFUN ® treatment after titrated dose administration for breakthrough pain in cancer patients on maintenance opioid therapy	CTRI/2010/091/000200 A PHASE 1 CLINICAL TRIAL, TO DETERMINE THE MAXIMUM TOLERATED DOSE AND THE DOSE LIMITING TOXICITY OF A NEW DRUG GENOPEP 1 (ISSAR 1) IN RELAPSED SOLID TUMOUR CANCER PATIENTS.	CTRI/2010/091/000136 A phase 1 study to evaluate the bioequivalence of two formulation of capecitabine Tablets 500 mg tablets in patients of Breast Cancer or Colorectal Cancer under fed condition.	CTRI/2009/091/000149 A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer
CTRI/2009/091/001060 A Phase 2 clincial trial to evaluate the Safety and Efficacy of drug FOLFIRI in Combination With drugs AMG 479 or AMG 655 Versus FOLFIRI for the Second-line Treatment of KRAS-mutant Metastatic Colorectal Cancer.	CTRI/2010/091/001052 A phase 2, open-label test-retest study to assess the reproducibility of quantitative measurements of 18F uptake by solid tumours using PET imaging following intravenous administration of AH111585 (18F) Injection	CTRI/2010/091/001297 A phase 3 clinial trial to study the effect of drug product Denosumab as adjuvant therapy for women with early-stage breast cancer, who are at high risk of disease recurrence ( D-CARE )	CTRI/2008/091/000236 A Phase I Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies
CTRI/2008/091/000004 A phase I/II clinical trial to study the safety and efficacy of a new compound P276-00 in the treatment of multiple myeloma	CTRI/2009/091/000159 A phase II clinical trial to study the efficacy and safety of a new drug P276-00 in treatment of recurrent and/or advanced head and neck cancer	CTRI/2009/091/000875 A Phase II study in patients with Extensive-Stage Small Cell Lung Cancer.	CTRI/2007/091/000023 A Phase III Study of Dasatinib vs. Imatinib in Patients With Newly Diagnosed Chronic Phase CML
CTRI/2009/091/000193 A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 10 mg ZD4054 in Combination with Docetaxel in comparison with Docetaxel in Patients with Metastatic Hormone-resistant Prostate Cancer	CTRI/2010/091/000596 A phase III/IV clinical study to assess the safety and efficacy of dendritic cell immunotherapy in advanced stage ovarian cancer.	CTRI/2010/091/000109 A post marketing surveillance trial to study the safety and efficacy of two drugs, Neupeg and Neulastim in female patients with advanced breast cancer.	CTRI/2011/091/000206 A Post-Marketing Surveillance Study to assess the safety and efficacy of Cetuximab plus Radiotherapy (RT) in Locally Advanced Squamous Cell Carcinoma of Head & Neck (LA SCCHN)
CTRI/2009/091/001007 A prospective study to determine the occurrence of hypothyroidism following treatment with radiation therapy in patients of head and neck carcinomas and the influencing factors	CTRI/2010/091/001406 a randomized controlled trial comparing modified gemcitabine+oxaliplatin(mGEMOX) to gemcitabine+cisplatin in management of unresectable gall bladder cancer.	CTRI/2010/091/001403 A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in patients with Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small Cell Lung Cancer.	CTRI/2010/091/001402 A Randomized, Open-Label, Phase 2 Trial of Paclitaxel/Carboplatin With or Without Bavituximab in Patients with Previously Untreated Locally Advanced or Metastatic Non- Squamous Non-Small Cell Lung Cancer.
CTRI/2010/091/000427 A study looking at benefit of oral non digestible starch in reducing rectal pain and diarrhea in patients undergoing radiation for treatment of cancer cervix - A pilot phase to assess feasibility.	CTRI/2007/091/000034 A study Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder.	CTRI/2009/091/001024 A Study of AVE8062 in Advanced-Stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies.	CTRI/2009/091/000195 A Study of Galiximab + Rituximab Versus Rituximab + Placebo in patients with Follicular Non-Hodgkin`s Lymphoma (NHL).
CTRI/2009/091/000113 A Study of Induction and Maintenance Treatment of Advanced Non-Squamous Non Small Cell Lung Cancer	CTRI/2007/091/000037 A Study of Mycobacterium w in Combination with Paclitaxel plus Cisplatin in Advanced NSCLC	CTRI/2009/091/000942 A Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxel as First-Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic Breast Cancer	CTRI/2010/091/000177 A study to assess the benefit of using growth factors in addition to antibiotics in children with febrile neutropenia.
CTRI/2008/091/000029 A study to assess the effect of two chemotherapy drugs (paclitaxel and Cisplatin) along with radiation in treating cancer of the uterine cervix	CTRI/2011/091/000221 A Study to determine the Factors Affecting the Survival in Patients with Gastric cancer Undergoing Surgery	CTRI/2007/091/000043 A study to determine the safety and activity of a novel oral agent, AV-951, in patients with kidney cancer To determine the safety and efficacy of AV-951 for the treatment in patients with Renal cell carcinoma.	CTRI/2008/091/000017 A study to determine the safety and activity of Sorafenib in patients with locally recurrent or metastatic breast cancer
CTRI/2007/091/000033 A study to evaluate the effect of immunoadjuvant therapy with Mycobacterium w and Docetaxel in Metastatic Hormone Refractory Prostate Cancer.	CTRI/2010/091/002961 A study to evaluate the Efficacy and Safety of AZD8931 in Combination with Anastrozole, compared to Anastrozole alone in Post-menopausal Women With Locally-advanced or Metastatic Breast Cancer.	CTRI/2011/091/000299 A Study to Evaluate the Safety and Efficacy of Anamorelin HCL in Patients with Non Small Cell Lung Cancer	PROVCTRI/2009/091/000299 A Study to Evaluate the Safety and Efficacy of Anamorelin HCL in Patients with Non Small Cell Lung Cancer
CTRI/2009/091/000499 ADJ109493 : A study to assess the efficacy of Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer	CTRI/2008/091/000042 Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer	CTRI/2010/091/000025 An Extension Treatment Protocol for Subjects who have Participated in AV-951-09-301 study.	CTRI/2009/091/000139 An Imaging Phase I B Study Evaluating MK-0646 in Combination with Erlotinib for Patients with Advanced Non-Small Cell Lung Cancer
CTRI/2008/091/000193 An invivo study to evaluate the role of curcumin in oral pre-malignant lesions and gingivo-buccal cancers	CTRI/2010/091/000170 An Observational Study to evaluate the safety and efficacy of Cetuximab in combination with platinum-based chemotherapy, in the first-line therapy of recurrent/ metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)	CTRI/2010/091/000161 An observational study to evaluate the safety and efficacy of FOLFIRI / FOLFOX plus Cetuximab as first-line therapy in patients with KRAS wild-type metastatic Colorectal cancer.	CTRI/2009/091/000181 An observational study to see the effect of chemotherapy (docetaxel+platinum)when given prior to surgery/radiotherapy in Locally advanced breast cancer patients.
CTRI/2010/091/000624 An Open Label Randomized Controlled Phase II Study of AS1411 Combined With Cytarabine in the Treatment of Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia	CTRI/2009/091/000565 Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer	CTRI/2010/091/000619 Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer.	CTRI/2010/091/000328 Bioequivalence Study of 6-Mercaptopurine in Adult patients with Acute Lymphoblastic Leukemia.
CTRI/2008/091/000111 Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Cancer	CTRI/2009/091/000827 Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status	CTRI/2009/091/000822 Clinical trial examining the vascular disrupting agent NPI-2358 combined with docetaxel in patients with advanced non-small cell lung cancer (NSCLC).	CTRI/2009/091/000160 Clinical Trial of Deforolimus Compared to Progestin in Endometrial Carcinoma Following One Line of Chemotherapy
CTRI/2010/091/000531 Duct-to-mucosa and dunking methods of pancreaticojejunostomy after pancreaticoduodenectomy- A randomized clinical trial.	CTRI/2010/091/001205 Early Detection of Common Cancers in Women in India	CTRI/2008/091/000056 Effect of no head shaving in Neurosurgery on the risk of wound infection	CTRI/2010/091/000372 Efficacy and safety of 1.0 molar gadobutrol (Gadovist®) versus unenhanced imaging in newly disgnosed breast cancer patients using MRI.
CTRI/2009/091/000345 Efficacy and Safety of MORAb-003 in Subjects With Platinum-Sensitive Ovarian Cancer in First Relapse.	CTRI/2010/091/001116 Efficacy and safety of paclitaxel nano-dispersion concentrate for injection (PICN) in subjects with metastatic breast cancer: A randomized, open label, active controlled, comparative, parallel group, and multi-centric study	CTRI/2011/091/000193 Efficacy of Pasteurization of resected tumor bearing bone and immediate reimplantation in surgical treatment of malignant bone tumours	CTRI/2009/091/000486 EGF102988 : This is a randomised, double-blind, placebo-controlled, multicentre, global Phase III trial comparing the efficacy of adjuvant oral lapatinib versus placebo in high-risk subjects with head and neck cancer following surgery. Lapatinib or placebo will be administered post-operatively in combination with chemoradiotherapy followed by maintenance with lapatinib or placebo for 1 year. The primary goal is to determine if lapatinib is effective at reducing the recurrence of the disease in these high-risk patients.
CTRI/2009/091/000495 EGF105485: Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer	CTRI/2009/091/000519 EGF105884: Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Head And Neck Cancer	CTRI/2009/091/000478 EGF106708 : Phase-III trial with adjuvant treatment of patients with ErbB2 overexpressing and/or amplified breast cancer who have undegone masectomy and have received at least four cycles of an approved anthracycline-based (neo-) adjuvant chemotherapy regimen.	CTRI/2009/091/000477 EGF106903 : Phase-III trial in women with HER2/Erb2 positive primary breast cancer using neoadjuvant chemotherapy.
CTRI/2009/091/000498 EGF110656 : LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib	CTRI/2011/091/000187 Evaluation of curcumin-piperine, and Ashwagandha root powder in the management of osteosarcoma.	CTRI/2008/091/000131 Evaluation of the efficacy of curcumin in the management of advanced cancer cervix.	CTRI/2011/091/000189 Evaluation of Zolendronic acid as a single agent or an adjuvant to chemotherapy in the management of high grade osteosarcoma.
CTRI/2010/091/000609 Everolimus as Monotherapy Treatment In First Line Metastatic Recurrent and/or Unresectable Renal Cell Carcinoma.	CTRI/2009/091/000213 Feasibility of intraoperative ultrasound based approach for safe and maximal resection of brain tumors.	CTRI/2009/091/000810 Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment With Sorafenib.	CTRI/2009/091/000506 Imatinib In Adjuvant GIST
CTRI/2010/091/000190 Imatinib pharmacokinetics and its correlation with response and safety in Indian children and adults with chronic phase chronic myeloid leukemia.	CTRI/2010/091/000381 IY5511 HCL for chronic Myelogenous leukemia.	CTRI/2009/091/000348 Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent	CTRI/2010/091/001182 NonSquamous Non-Small Cell Lung Cancer treatment with the Inhibitor of Epidermal growth factor receptor
CTRI/2009/091/000483 OMB110911 : Ofatumumab + Chlorambucil vs. Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia	CTRI/2010/091/001145 OMB112517: Ofatumumab Maintenance Treatment versus No Further Treatment in Relapsed CLL Responding to Induction Therapy	CTRI/2009/091/000885 Open-label clinical trial of Enoxaparin (low molecular weight heparin) given concomitantly with chemotherapy vs chemotherapy alone in patients with inoperable gastric and gastro-oesophageal cancer.	CTRI/2009/091/000262 Phase 1 safety, efficacy, and pharmacokinetic study of Paclitaxel nano-dispersion injection in subjects with metastatic breast cancer: A randomized, open label, dose-ranging, active controlled, comparative, parallel group, and multi-centric study.
CTRI/2010/091/001122 Phase 1 safety, tolerability, and pharmacokinetic study of Docetaxel nano-dispersion: A randomized, open label, dose ranging, active controlled, comparative, parallel groups, and multi-centric study.	CTRI/2009/091/000857 Phase 1b/2 clinical trial in patients with cancer to Evaluate the Safety and Efficacy of First-line Treatment With Epirubicin, Cisplatin, and Capecitabine(ECX) Plus drug AMG 102.	CTRI/2009/091/000743 Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab	CTRI/2010/091/000277 Phase 3 clinical Study to Compare the Efficacy and Safety of drug product Panitumumab and Cetuximab in Subjects with Previously Treated Metastatic Colorectal Cancer.
CTRI/2007/091/000039 Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)	CTRI/2008/091/000195 Phase II/III Randomized Placebo Controlled Clinical Trial of Curcumin in Resectable Stage III and IV Squamous Head and Neck Cancers (Oral cancers)	CTRI/2009/091/000742 Phase III clinical trial for Evaluation of Efficacy and Safety of IN-ALRN-001 in Comparison with Tamsulosin in Patients with lower urinary tract symptoms associated with BPH.	CTRI/2009/091/001016 Phase III clinical trial to compare the efficacy and safety of pegylated granulocyte colony stimulating factor(Peg G-CSF) versus granulocyte colony stimulating factor (G-CSF) in nonmyeloid malignancies subjects .
CTRI/2008/091/000016 Phase III Randomized Trial of Maintenance Pegylated Liposomal Doxorubicin (PLD) / Carboplatin versus without in Patients with Advanced Ovarian Cancer	CTRI/2010/091/001360 Phase III Trial of Vinorelbine+BIBW 2992 vs Vinorelbine+Herceptin in BC Patients After Failing Herceptin Treatment	CTRI/2010/091/001233 Phase III, double-blind, placebo-controlled study of post-operative adjuvant concurrent chemo-radiotherapy with or without nimotuzumab for stage III/IV head and neck squamous cell cancer	CTRI/2010/091/001230 Phase III, double-blind, placebo-controlled study of post-operative adjuvant concurrent chemo-radiotherapy with or without nimotuzumab for stage III/IV head and neck squamous cell cancer
CTRI/2010/091/000441 Phase III, Multi-centre, Double Blind, Randomized Placebo Controlled Trial of Aspirin for Duke C and High Risk Dukes B Colorectal Cancers.	CTRI/2010/091/000428 PILOT Phase of a trial looking at benefits of Hyperfractionated IMRT in locally advanced head and neck cancer.	CTRI/2010/091/000583 POsterolateral Thoracotomy versus Nerve Sparing Thoracotomy - A Prospective Trial.	CTRI/2009/091/000559 Radiation Treatment Of Bladder Cancer With Tomotherapy/ Intensity Modulated Radio Therapy (IMRT)
CTRI/2010/091/001329 Randomised trial to study the additional impact of brachytherapy (internal radiation) over high precision external radiotherapy for reduction of dryness of mouth in patients with early stage cancer of oropharynx.	CTRI/2010/091/001281 Research study to assess safety & efficacy in patients which are facing recurrence of ovarian cancer and are resistant to already established platinum based therapy by administering 4 hr infusion of ON 01910.Na	CTRI/2010/091/001478 Research study to demonstrate that Intravenous iron isomaltoside is non-inferior to Oral iron sulphate in reducing iron deficiency in non-myeloid malignancies subjects associated with chemotherapy induced anaemia ,evaluated as ability to increase Haemoglobin (Hb).	CTRI/2010/091/000034 Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer.
CTRI/2009/091/000660 STRIDE - A Randomised, Double-Blind, Phase III Study of Stimuvax® in combination with Hormonal Treatment versus Hormonal Treatment alone for First-line Therapy of endocrine-sensitive Advanced Breast Cancer.	CTRI/2009/091/000424 Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects	CTRI/2009/091/000362 Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer	CTRI/2008/091/000128 Study of Bavituximab plus Paclitaxel and Carboplatin in patients with Non small Cell Lung Cancer.
CTRI/2009/091/000664 Study of Mycobacterium w in BCG refractory Superficial Transitional Cell Carcinoma of Bladder	CTRI/2010/091/000255 Study to Compare Zoladex 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer.	CTRI/2009/091/000146 Study to determine the safety, tolerability, and anti-tumor effectiveness of an oral investigational drug, suberoylanilide hydroxamic acid (Vorinostat, MK-0683), in the treatment of advanced malignant pleural mesothelioma.	CTRI/2009/091/000574 Study to evaluate the efficacy and tolerability of Filgrastim in chemotherapy induced neutropenia
CTRI/2009/091/000579 Study to evaluate the efficacy and tolerability of Pegfilgrastim in chemotherapy induced neutropenia	CTRI/2010/091/000023 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF rhG-CSF THERAPY FOR MYELOSUPPRESSIVE CHEMOTHERAPY INDUCED NEUTROPENIA	CTRI/2009/091/000283 Study to evaluate the safety and efficacy of TULY (rasburicase) in prevention and treatment of malignancy-associated hyperuricemia	CTRI/2009/091/000354 The purpose of this study is to evaluate the efficacy (disease response) and safety of mapatumumab in combination with bortezomib and bortezomib alone in subjects with relapsed or refractory multiple myeloma (MM).
CTRI/2010/091/001298 This is a multicenter, open-label, two-arm, Phase 2 clinical study and will be conducted in male and female subjects aged 18 years and older with advanced NSCLC who have progressed after first line therapy, to evaluate the safety and efficacy of erlotinib in combination with CS-7017.	CTRI/2011/091/000021 This is a Neoadjuvant Study of AC Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer That is HER-2 Negative and Estrogen Receptors Negative	PROVCTRI/2007/091/000021 This is a Neoadjuvant Study of AC Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer That is HER-2 Negative and Estrogen Receptors Negative	CTRI/2010/091/001144 This is an early phase clinical trial where the main aim is to determine the highest dose level of the study drug, E7389 that can be given together (in combination) with a chemotherapeutic drug, carboplatin, in patients with solid tumors.
CTRI/2008/091/000013 This lung cancer study is to investigate if adding vandetanib (ZD 6474) to Alimta (pemetrexed) is more effective than Alimta (pemetrexed) alone in Patients with Locally Advanced or Metastatic (stage IIIB or IV) Non-Small Cell Lung Cancer (NSCLC) after Failure of 1st Line Anti-cancer Therapy	CTRI/2009/091/000207 This study is to evaluate the safety and tolerability of Fluphenazine HCl Monotherapy in patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma	CTRI/2010/091/001263 This study tests the safety and effectiveness of CNTO 328 when it is taken together with VMP (Velcade, melphalan, and prednisone) in comparison with VMP alone in patients with multiple myeloma.	CTRI/2009/091/000521 To access the toxicity and efficacy of altered fractionation radiotherapy without chemotherapy in medulloblastoma
CTRI/2009/091/000073 To compare the efficacy and safety of low-dose versus standard-dose Filgrastim in chemotherapy induced Neutropenia.	CTRI/2008/091/000045 To compare two advanced high-precision radiotherapy techniques in head and neck cancers.	CTRI/2008/091/000249 To see whether by applying a pressure bandage in the arm can reduce the incidence of swelling of the arm in the side in patients who undergoes surgery for carcinoma breast	CTRI/2011/091/000208 To study efficacy and safety of Oxaliplatin as an adjuvant to chemotherapy in metastatic colon cancer.
CTRI/2009/091/000015 To study role of two different chemotherapy regimen and best supportive care in advance not surgically fit gall bladder cancer patient.	CTRI/2010/091/002818 To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)	CTRI/2009/091/000851 Toxicity with Tomotherapy based Intensity Modified Radiation Therapy in Head and Neck cancers and in vivo prediction of radio-responsiveness of oropharyngeal cancers using Raman Spectroscopy.	CTRI/2009/091/000566 Treatment of patients with Aggressive Lymphoma following Self Stem Cell Transplantation
CTRI/2010/091/001232 Treatment of Recurrent Cervix Cancer ( Following treatment, cancer has returned to the cervix ) with ADXS11-001 (the experimental drug) with and without Cisplatin as 2 nd Line Therapy (failed on prior treatment)	CTRI/2011/091/000186 Trial for optimal surveillance in sarcomas	CTRI/2009/091/000516 VEG105424 : Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)